1-3 of 3
Françoise Boyer, MD
Close
Sort by
Journal Articles

Comparison of the Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Across Nine Linguistic Translations Among an International Sample of 1,851 Myeloproliferative Neoplasm (MPN) Patients.

Amylou Constance Dueck, PhD, Robyn M. Emanuel, MD, MPH, Holly Lynn Geyer, MD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD, PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, MSc, Harry C Schouten, MD, PhD, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernandez, MD, Heike L. Pahl, PhD, Martin Griesshammer, MD, PhD, Frank Stegelmann, MD, Konstanze Doehner, Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, MD, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N Harrison, DM FRCP FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Ayalew Tefferi, MD, Zhijian Xiao, MD, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Gale, Ruben A. Mesa
Journal: Blood
Blood (2012) 120 (21): 2852.
https://doi.org/10.1182/blood.V120.21.2852.2852
Published: 2012
Journal Articles

The Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Derived Total Symptom Score (TSS): An International Trial of 1433 Patients with Myeloproliferative Neoplasms (MPNs),

Robyn Scherber, MPH, Medical-Student, Amylou Dueck, PhD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD, PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, MSc, Harry C. Schouten, MD, PhD, Federico Sackmann, Ana Kerguelen Fuentes, MD, Dolores Hernandez-Maraver, PhD, Heike L. Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, Prof., Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, MD, Gabriel Etienne, MD, PhD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, Jean-Yves Cahn, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti Radia, MD, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, Jan Samuelsson, MD, PhD, Gunnar Birgegard, MD, PhD, Ayalew Tefferi, MD, Ruben A. Mesa, MD
Journal: Blood
Blood (2011) 118 (21): 3839.
https://doi.org/10.1182/blood.V118.21.3839.3839
Published: 2011
Journal Articles

Pegylated Interferon Alpha-2a Therapy for Patients with High Risk Essential Thrombocytemia: a Retrospective Analysis on 59 Patients.On Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)

Lydia Roy, MD, Jean Christophe Ianotto, MD, Joelle Guilhot, MBci, Emmanuel Raffoux, MD, Emmanuel Gyan, MD, PhD, Benoit de Renzis, MD, Laurence Legros, MD, Jean-François Viallard, MD-PhD, Françoise Boyer, MD, Cony Makhoul, MD, Franck E Nicolini, MD, PhD, Jean Gunecht, MD, Stephane Giraudier, MD-PhD
Journal: Blood
Blood (2010) 116 (21): 1974.
https://doi.org/10.1182/blood.V116.21.1974.1974
Published: 2010